Clinical Trial in UC

elevate-logo

Now Enrolling

It’s time to rise up against UC

Etrasimod is an investigational, once-daily, oral S1P receptor modulator designed to selectively target S1P1, S1P4, and S1P5, with no observed activity for S1P2 and S1P3 at therapeutic doses.*